Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.013587605288348507,6.829842032967033,29.3587403697076,"['DYRK1A', 'NFATC2', 'PDK1']",0.8673999965411625,0,0,3
2,PKC-gamma calcium signaling pathway in ataxia WP4760,0.013587605288348507,6.829842032967033,29.3587403697076,"['CACNA1A', 'ATP2B2', 'PDK1']",0.8673999965411625,0,0,3
3,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.022948636792460477,5.462225274725275,20.61715151040904,"['SERPINH1', 'P3H2', 'PLOD2']",0.8673999965411625,0,0,3
4,Arylamine metabolism WP694,0.02690204606121906,inf,inf,['SULT1A1'],0.8673999965411625,0,0,1
5,Hematopoietic Stem Cell Differentiation WP2849,0.03176388148330697,4.748686096512183,16.380238614207798,"['THRB', 'MXI1', 'NFATC2']",0.8673999965411625,0,0,3
6,Nuclear receptors WP170,0.03848717303846923,4.368131868131868,14.228884931435788,"['NR4A2', 'NR4A1', 'THRB']",0.8673999965411625,0,0,3
7,Zinc homeostasis WP3529,0.042098437723352006,4.1998098055790365,13.303925032944537,"['SLC30A9', 'SLC30A1', 'SLC39A12']",0.8673999965411625,0,0,3
8,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.04629067913912671,6.607222914072229,20.30277138366044,"['RAB27A', 'SYTL3']",0.8673999965411625,0,0,2
9,Ciliary landscape WP4352,0.04937554591268771,1.8887348753934563,5.68188112444202,"['EXOSC7', 'NEK8', 'AFG3L2', 'INTU', 'TFAP2E', 'EIPR1', 'EXOSC9', 'XPNPEP3', 'DCAF7', 'LRPPRC']",0.8673999965411625,0,0,10
10,DNA Replication WP466,0.0625621373147277,3.521091811414392,9.759040526277147,"['POLD3', 'RFC3', 'ORC3']",0.8673999965411625,0,0,3
11,Urea cycle and metabolism of amino groups WP497,0.0752594445927076,4.843835616438356,12.530101174482171,"['GLUD1', 'ACY1']",0.8673999965411625,0,0,2
12,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.07856024632460144,18.132513661202186,46.12711073861389,['TRAF3'],0.8673999965411625,0,0,1
13,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.07856024632460144,18.132513661202186,46.12711073861389,['GLUD1'],0.8673999965411625,0,0,1
14,let-7 inhibition of ES cell reprogramming WP3299,0.07856024632460144,18.132513661202186,46.12711073861389,['KLF4'],0.8673999965411625,0,0,1
15,Calcium Regulation in the Cardiac Cell WP536,0.09000235871327518,2.0075732547205773,4.8340745891109504,"['RGS5', 'PKIB', 'CACNA1A', 'ATP1B3', 'CACNA1D', 'ATP2B2']",0.8673999965411625,0,0,6
16,7-oxo-C and 7beta-HC pathways WP5064,0.09981267978046589,4.035616438356165,9.29991686668674,"['CYP27A1', 'ACOT11']",0.8673999965411625,0,0,2
17,Striated Muscle Contraction Pathway WP383,0.09981267978046589,4.035616438356165,9.29991686668674,"['ACTN2', 'MYL3']",0.8673999965411625,0,0,2
18,Retinoblastoma gene in cancer WP2446,0.10167283498846258,2.3483515506975916,5.36832018697196,"['POLD3', 'RFC3', 'PRKDC', 'HMGB1']",0.8673999965411625,0,0,4
19,Cytosolic DNA-sensing pathway WP4655,0.10291321296864805,2.797125950972105,6.360298656043068,"['IL33', 'TRIM25', 'ISG15']",0.8673999965411625,0,0,3
20,Tamoxifen metabolism WP691,0.10335442578389262,12.087431693989071,27.43352824683875,['SULT1A1'],0.8673999965411625,0,0,1
21,The alternative pathway of fetal androgen synthesis WP4524,0.10335442578389262,12.087431693989071,27.43352824683875,['CYP11A1'],0.8673999965411625,0,0,1
22,EPO Receptor Signaling WP581,0.10843224212204663,3.822927180966114,8.493128939487416,"['SHC1', 'PDK1']",0.8673999965411625,0,0,2
23,Type II interferon signaling (IFNG) WP619,0.11724025732551807,3.6315068493150684,7.784243761523586,"['ISG15', 'GBP1']",0.8673999965411625,0,0,2
24,DNA Mismatch Repair WP531,0.11724025732551807,3.6315068493150684,7.784243761523586,"['POLD3', 'RFC3']",0.8673999965411625,0,0,2
25,Serotonin Transporter Activity WP1455,0.12748321428680215,9.064890710382514,18.671595157210813,['MAOA'],0.8673999965411625,0,0,1
26,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.12748321428680215,9.064890710382514,18.671595157210813,['CYP11A1'],0.8673999965411625,0,0,1
27,Vitamin D Metabolism WP1531,0.12748321428680215,9.064890710382514,18.671595157210813,['CYP27A1'],0.8673999965411625,0,0,1
28,Molybdenum cofactor (Moco) biosynthesis WP4507,0.12748321428680215,9.064890710382514,18.671595157210813,['GPHN'],0.8673999965411625,0,0,1
29,NAD Biosynthesis II (from tryptophan) WP2485,0.12748321428680215,9.064890710382514,18.671595157210813,['NADSYN1'],0.8673999965411625,0,0,1
30,Osteoblast Signaling WP322,0.12748321428680215,9.064890710382514,18.671595157210813,['BGLAP'],0.8673999965411625,0,0,1
31,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.13217403656861326,2.4783341658341658,5.0152456579486815,"['TRAF3', 'TRIM25', 'ISG15']",0.8673999965411625,0,0,3
32,Genes related to primary cilium development (based on CRISPR) WP4536,0.13224311861104607,1.916254725210817,3.8768003111219915,"['ARMC9', 'CEP83', 'FGFR1OP', 'TUBD1', 'WDR35']",0.8673999965411625,0,0,5
33,Gastric Cancer Network 2 WP2363,0.13535715297263412,3.3008717310087174,6.601210095111689,"['RFC3', 'DSCC1']",0.8673999965411625,0,0,2
34,Mesodermal commitment pathway WP2857,0.1486764556147072,1.8382722250125565,3.5037151926933974,"['EPB41L5', 'UBR5', 'HMGA2', 'KLF4', 'PIAS1']",0.8673999965411625,0,0,5
35,Sulfation Biotransformation Reaction WP692,0.15096441933491855,7.251366120218579,13.710238438872343,['SULT1A1'],0.8673999965411625,0,0,1
36,Aspirin and miRNAs WP4707,0.15096441933491855,7.251366120218579,13.710238438872343,['PDK1'],0.8673999965411625,0,0,1
37,Peroxiredoxin 2 induced ovarian failure WP4873,0.15096441933491855,7.251366120218579,13.710238438872343,['CYP11A1'],0.8673999965411625,0,0,1
38,Vitamin D Receptor Pathway WP2877,0.1530988268406645,1.9928299181101174,3.739887388762873,"['BGLAP', 'NFATC2', 'CD9', 'KLF4']",0.8673999965411625,0,0,4
39,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.15404158231524034,3.0253424657534245,5.659002004785203,"['CYP11A1', 'PDK1']",0.8673999965411625,0,0,2
40,Oxidation by Cytochrome P450 WP43,0.15404158231524034,3.0253424657534245,5.659002004785203,"['CYP27A1', 'CYP11A1']",0.8673999965411625,0,0,2
41,Oxysterols derived from cholesterol WP4545,0.15404158231524034,3.0253424657534245,5.659002004785203,"['CYP27A1', 'ACOT11']",0.8673999965411625,0,0,2
42,Melatonin metabolism and effects WP3298,0.163561574452488,2.904109589041096,5.258081377613358,"['SULT1A1', 'MAOA']",0.8673999965411625,0,0,2
43,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.16393487235129195,2.2246019286835614,4.022716634085837,"['ACTN2', 'ITGA7', 'CACNA1D']",0.8673999965411625,0,0,3
44,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.16393487235129195,2.2246019286835614,4.022716634085837,"['RSAD2', 'ISG15', 'IFI44L']",0.8673999965411625,0,0,3
45,Biogenic Amine Synthesis WP550,0.17381537392466154,6.0423497267759565,10.572671601204966,['MAOA'],0.8673999965411625,0,0,1
46,Estrogen metabolism WP697,0.17381537392466154,6.0423497267759565,10.572671601204966,['SULT1A1'],0.8673999965411625,0,0,1
47,Role of Osx and miRNAs in tooth development WP3971,0.17381537392466154,6.0423497267759565,10.572671601204966,['KLF4'],0.8673999965411625,0,0,1
48,Base Excision Repair WP4752,0.18289263401421274,2.688584474885845,4.56751786046149,"['POLD3', 'HMGB1']",0.8673999965411625,0,0,2
49,Proximal tubule transport WP4917,0.18289263401421274,2.688584474885845,4.56751786046149,"['SLC13A3', 'SLC47A1']",0.8673999965411625,0,0,2
50,Supression of HMGB1 mediated inflammation by THBD WP4479,0.196052948821815,5.178766588602654,8.438129553420152,['HMGB1'],0.8673999965411625,0,0,1
51,Heme Biosynthesis WP561,0.196052948821815,5.178766588602654,8.438129553420152,['FECH'],0.8673999965411625,0,0,1
52,Leptin and adiponectin WP3934,0.196052948821815,5.178766588602654,8.438129553420152,['LEPR'],0.8673999965411625,0,0,1
53,Focal Adhesion WP306,0.196335905630669,1.5706969050798143,2.5569819148579924,"['SHC1', 'COL5A2', 'TESK2', 'ITGA7', 'PARVB', 'MYLK']",0.8673999965411625,0,0,6
54,Vitamin D-sensitive calcium signaling in depression WP4698,0.20253280373954435,2.502786962683042,3.996583900317894,"['CYP27A1', 'ATP2B2']",0.8673999965411625,0,0,2
55,Serotonin and anxiety-related events WP3944,0.2176935645321357,4.531079234972678,6.908386405573415,['PLCD4'],0.8673999965411625,0,0,1
56,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.2176935645321357,4.531079234972678,6.908386405573415,['KLF4'],0.8673999965411625,0,0,1
57,Cytosine methylation WP3585,0.2176935645321357,4.531079234972678,6.908386405573415,['TET3'],0.8673999965411625,0,0,1
58,Dopamine metabolism WP2436,0.2176935645321357,4.531079234972678,6.908386405573415,['MAOA'],0.8673999965411625,0,0,1
59,NLR Proteins WP288,0.2176935645321357,4.531079234972678,6.908386405573415,['ERBIN'],0.8673999965411625,0,0,1
60,Parkinson's disease pathway WP2371,0.22239510589010217,2.3409633230225366,3.5191695144388366,"['GPR37', 'UBA7']",0.8673999965411625,0,0,2
61,15q13.3 copy number variation syndrome WP4942,0.23875320336783273,4.027322404371585,5.768434089485524,['SERPINH1'],0.8673999965411625,0,0,1
62,TCA cycle in senescence WP5050,0.23875320336783273,4.027322404371585,5.768434089485524,['PDK1'],0.8673999965411625,0,0,1
63,Development and heterogeneity of the ILC family WP3893,0.23875320336783273,4.027322404371585,5.768434089485524,['IL33'],0.8673999965411625,0,0,1
64,Eicosanoid Synthesis WP167,0.23875320336783273,4.027322404371585,5.768434089485524,['PLA2G5'],0.8673999965411625,0,0,1
65,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.23875320336783273,4.027322404371585,5.768434089485524,['H2AFY'],0.8673999965411625,0,0,1
66,Non-homologous end joining WP438,0.23875320336783273,4.027322404371585,5.768434089485524,['PRKDC'],0.8673999965411625,0,0,1
67,Fas ligand pathway and stress induction of heat shock proteins WP314,0.24240088035590016,2.198754669987547,3.115992429656587,"['PRKDC', 'NFX1']",0.8673999965411625,0,0,2
68,Tryptophan catabolism leading to NAD+ production WP4210,0.2592474208898312,3.6243169398907105,4.8927277662103705,['NADSYN1'],0.8673999965411625,0,0,1
69,Dopaminergic Neurogenesis WP2855,0.2592474208898312,3.6243169398907105,4.8927277662103705,['NR4A2'],0.8673999965411625,0,0,1
70,Ganglio Sphingolipid Metabolism WP1423,0.2592474208898312,3.6243169398907105,4.8927277662103705,['ST8SIA1'],0.8673999965411625,0,0,1
71,Homologous recombination WP186,0.2592474208898312,3.6243169398907105,4.8927277662103705,['POLD3'],0.8673999965411625,0,0,1
72,Leptin Insulin Overlap WP3935,0.2592474208898312,3.6243169398907105,4.8927277662103705,['LEPR'],0.8673999965411625,0,0,1
73,Matrix Metalloproteinases WP129,0.2592474208898312,3.6243169398907105,4.8927277662103705,['MMP16'],0.8673999965411625,0,0,1
74,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.27252524607603174,2.015068493150685,2.619637449125903,"['TRAF3', 'TRIM25']",0.8673999965411625,0,0,2
75,Endoderm differentiation WP2853,0.2765117341113125,1.5287806292590982,1.9652505884324039,"['EPB41L5', 'UBR5', 'LRPPRC', 'PIAS1']",0.8673999965411625,0,0,4
76,Serotonin and anxiety WP3947,0.27919135738549083,3.2945851962245403,4.20342242956079,['PLCD4'],0.8673999965411625,0,0,1
77,Cancer immunotherapy by PD-1 blockade WP4585,0.27919135738549083,3.2945851962245403,4.20342242956079,['NFATC2'],0.8673999965411625,0,0,1
78,Cell Differentiation - Index expanded WP2023,0.27919135738549083,3.2945851962245403,4.20342242956079,['KLF4'],0.8673999965411625,0,0,1
79,Fatty acid transporters WP5061,0.27919135738549083,3.2945851962245403,4.20342242956079,['FABP5'],0.8673999965411625,0,0,1
80,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.28256603280190484,1.9604590892262126,2.4777125188151645,"['NFATC2', 'PDK1']",0.8673999965411625,0,0,2
81,Amino Acid metabolism WP3925,0.29118109901824596,1.6247334754797442,2.004612201389348,"['GLUD1', 'MAOA', 'FARSB']",0.8673999965411625,0,0,3
82,Corticotropin-releasing hormone signaling pathway WP2355,0.29118109901824596,1.6247334754797442,2.004612201389348,"['NR4A2', 'NR4A1', 'CYP11A1']",0.8673999965411625,0,0,3
83,Interleukin-11 Signaling Pathway WP2332,0.2925945433738801,1.9087238644556597,2.3457594800812513,"['BGLAP', 'PIAS1']",0.8673999965411625,0,0,2
84,VEGFA-VEGFR2 Signaling Pathway WP3888,0.2977635022424635,1.2161481423359095,1.4733096284997116,"['NR4A2', 'GLUD1', 'NR4A1', 'NR4A3', 'TFCP2', 'SHC1', 'DHX36', 'EIF2AK3', 'NFATC2', 'PLA2G5', 'HMGB1', 'FARSB']",0.8673999965411625,0,0,12
85,Hypertrophy Model WP516,0.29859974876982365,3.0198087431693987,3.64989556761321,['NR4A3'],0.8673999965411625,0,0,1
86,Omega-3/Omega-6 FA synthesis WP4723,0.29859974876982365,3.0198087431693987,3.64989556761321,['PLA2G5'],0.8673999965411625,0,0,1
87,Riboflavin and CoQ disorders WP5037,0.29859974876982365,3.0198087431693987,3.64989556761321,['APTX'],0.8673999965411625,0,0,1
88,ATM Signaling Network in Development and Disease  WP3878,0.3026041871693028,1.8596417281348787,2.2228848781939416,"['RNF20', 'PRKDC']",0.8673999965411625,0,0,2
89,Airway smooth muscle cell contraction WP4962,0.317486937548213,2.787305590584279,3.197927556535527,['MYLK'],0.8673999965411625,0,0,1
90,Type II diabetes mellitus WP1584,0.317486937548213,2.787305590584279,3.197927556535527,['CACNA1A'],0.8673999965411625,0,0,1
91,SARS coronavirus and innate immunity WP4912,0.317486937548213,2.787305590584279,3.197927556535527,['TRAF3'],0.8673999965411625,0,0,1
92,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.32254230542096884,1.7686602071500168,2.001276116289409,"['PPP1R13B', 'EIF2AK3']",0.8673999965411625,0,0,2
93,Nucleotide Excision Repair WP4753,0.3324593486729434,1.7264187866927594,1.9011974297085639,"['POLD3', 'RFC3']",0.8673999965411625,0,0,2
94,Constitutive Androstane Receptor Pathway WP2875,0.33586688298822287,2.588017174082748,2.8236312387344022,['SULT1A1'],0.8673999965411625,0,0,1
95,MAPK pathway in congenital thyroid cancer WP4928,0.33586688298822287,2.588017174082748,2.8236312387344022,['SHC1'],0.8673999965411625,0,0,1
96,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.33586688298822287,2.588017174082748,2.8236312387344022,['MYLK'],0.8673999965411625,0,0,1
97,Mitochondrial complex III assembly WP4921,0.33586688298822287,2.588017174082748,2.8236312387344022,['UQCRC2'],0.8673999965411625,0,0,1
98,Wnt Signaling Pathway WP363,0.34233463522734503,1.686142083466072,1.8074879199948688,"['NFATC2', 'CSNK1G1']",0.8673999965411625,0,0,2
99,Phosphoinositides metabolism WP4971,0.34233463522734503,1.686142083466072,1.8074879199948688,"['MTMR12', 'PLCD4']",0.8673999965411625,0,0,2
100,PPAR signaling pathway WP3942,0.34233463522734503,1.686142083466072,1.8074879199948688,"['CYP27A1', 'FABP5']",0.8673999965411625,0,0,2
101,DNA Repair Pathways Full Network WP4946,0.3434339109277963,1.3689900722490773,1.463122630307074,"['POLD3', 'RFC3', 'PRKDC', 'HMGB1']",0.8673999965411625,0,0,4
102,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.3537531716244883,2.4153005464480874,2.5098737269898375,['PLA2G5'],0.8673999965411625,0,0,1
103,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.3537531716244883,2.4153005464480874,2.5098737269898375,['SETX'],0.8673999965411625,0,0,1
104,miRNA targets in ECM and membrane receptors WP2911,0.3537531716244883,2.4153005464480874,2.5098737269898375,['COL5A2'],0.8673999965411625,0,0,1
105,Integrin-mediated Cell Adhesion WP185,0.35771346603750137,1.431354829381145,1.4714656675133966,"['SHC1', 'CAPN5', 'ITGA7']",0.8673999965411625,0,0,3
106,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3619405377671935,1.610958904109589,1.6371778095468248,"['PRKDC', 'HSF1']",0.8673999965411625,0,0,2
107,Globo Sphingolipid Metabolism WP1424,0.3711590270200332,2.2641734972677594,2.244078196621118,['ST8SIA1'],0.8673999965411625,0,0,1
108,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.3711590270200332,2.2641734972677594,2.244078196621118,['SHC1'],0.8673999965411625,0,0,1
109,Fragile X Syndrome  WP4549,0.38022436336810495,1.2950609996064542,1.25231591914159,"['SHC1', 'EIF4EBP2', 'GPHN', 'PDK1']",0.8673999965411625,0,0,4
110,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.3813240759214812,1.542174293208977,1.4868189839660004,"['MAOA', 'HMGA2']",0.8673999965411625,0,0,2
111,Translation Factors WP107,0.3813240759214812,1.542174293208977,1.4868189839660004,"['EIF2AK3', 'EIF4EBP2']",0.8673999965411625,0,0,2
112,Urea cycle and associated pathways WP4595,0.38809731947888354,2.1308261009321763,2.016825087812577,['GLUD1'],0.8673999965411625,0,0,1
113,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.38809731947888354,2.1308261009321763,2.016825087812577,['RAB27A'],0.8673999965411625,0,0,1
114,NAD+ biosynthetic pathways WP3645,0.38809731947888354,2.1308261009321763,2.016825087812577,['NADSYN1'],0.8673999965411625,0,0,1
115,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.404580575386246,2.012295081967213,1.8209346029919715,['TRAF3'],0.8673999965411625,0,0,1
116,Vitamin D in inflammatory diseases WP4482,0.404580575386246,2.012295081967213,1.8209346029919715,['DUSP1'],0.8673999965411625,0,0,1
117,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.404580575386246,2.012295081967213,1.8209346029919715,['H2AFY'],0.8673999965411625,0,0,1
118,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.404580575386246,2.012295081967213,1.8209346029919715,['PDK1'],0.8673999965411625,0,0,1
119,Hippo-Yap signaling pathway WP4537,0.404580575386246,2.012295081967213,1.8209346029919715,['TNIK'],0.8673999965411625,0,0,1
120,Peptide GPCRs WP24,0.404580575386246,2.012295081967213,1.8209346029919715,['OXTR'],0.8673999965411625,0,0,1
121,DNA damage response (only ATM dependent) WP710,0.40892885836397175,1.3099430689792135,1.1713695343135477,"['SHC1', 'HMGB1', 'PDK1']",0.8673999965411625,0,0,3
122,Ciliopathies WP4803,0.4102438075076362,1.2004683326625443,1.0696216583829414,"['NEK8', 'INTU', 'XPNPEP3', 'CEP83', 'WDR35']",0.8673999965411625,0,0,5
123,Sleep regulation WP3591,0.4206209865711675,1.906241012366983,1.6508487894076893,['OXTR'],0.8673999965411625,0,0,1
124,Immune response to tuberculosis WP4197,0.4206209865711675,1.906241012366983,1.6508487894076893,['PIAS1'],0.8673999965411625,0,0,1
125,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.42861226166677335,1.3933614330874604,1.180459411717701,"['SHC1', 'MYLK']",0.8673999965411625,0,0,2
126,Unfolded protein response WP4925,0.43623041885287883,1.810792349726776,1.502205613042937,['EIF2AK3'],0.8673999965411625,0,0,1
127,SARS-CoV-2 mitochondrial interactions WP5038,0.43623041885287883,1.810792349726776,1.502205613042937,['TRAF3'],0.8673999965411625,0,0,1
128,Metapathway biotransformation Phase I and II WP702,0.4376542639041632,1.2493368700265253,1.032359578596304,"['CYP27A1', 'SULT1A1', 'CYP11A1']",0.8673999965411625,0,0,3
129,Pathways affected in adenoid cystic carcinoma WP3651,0.44699374660785274,1.3415525114155251,1.0802324021352925,"['PRKDC', 'ERBIN']",0.8673999965411625,0,0,2
130,TLR4 Signaling and Tolerance WP3851,0.45142042121647885,1.7244340359094457,1.3715392603699195,['TRAF3'],0.8673999965411625,0,0,1
131,Toll-like Receptor Signaling related to MyD88 WP3858,0.45142042121647885,1.7244340359094457,1.3715392603699195,['TRAF3'],0.8673999965411625,0,0,1
132,Heart Development WP1591,0.45142042121647885,1.7244340359094457,1.3715392603699195,['NFATC2'],0.8673999965411625,0,0,1
133,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.45142042121647885,1.7244340359094457,1.3715392603699195,['ERBIN'],0.8673999965411625,0,0,1
134,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.46503970063331757,1.2934442270058708,0.9903029362705913,"['KREMEN1', 'KLF4']",0.8673999965411625,0,0,2
135,Endothelin Pathways WP2197,0.46620223387969983,1.645926477893691,1.2560653547887124,['MYLK'],0.8673999965411625,0,0,1
136,miRNAs involvement in the immune response in sepsis WP4329,0.46620223387969983,1.645926477893691,1.2560653547887124,['TRAF3'],0.8673999965411625,0,0,1
137,Oxidative Stress WP408,0.46620223387969983,1.645926477893691,1.2560653547887124,['MAOA'],0.8673999965411625,0,0,1
138,Photodynamic therapy-induced unfolded protein response WP3613,0.46620223387969983,1.645926477893691,1.2560653547887124,['EIF2AK3'],0.8673999965411625,0,0,1
139,Pre-implantation embryo WP3527,0.46620223387969983,1.645926477893691,1.2560653547887124,['KLF4'],0.8673999965411625,0,0,1
140,Prostaglandin Synthesis and Regulation WP98,0.46620223387969983,1.645926477893691,1.2560653547887124,['CYP11A1'],0.8673999965411625,0,0,1
141,Proteasome Degradation WP183,0.4739316769496305,1.2706560922855084,0.9487888775312533,"['UBA7', 'UBE2D1']",0.8673999965411625,0,0,2
142,16p11.2 distal deletion syndrome WP4950,0.4805867965732722,1.5742456640532192,1.1535244627213985,['NFATC2'],0.8673999965411625,0,0,1
143,TYROBP causal network in microglia WP3945,0.4805867965732722,1.5742456640532192,1.1535244627213985,['TMEM106A'],0.8673999965411625,0,0,1
144,White fat cell differentiation WP4149,0.4805867965732722,1.5742456640532192,1.1535244627213985,['KLF4'],0.8673999965411625,0,0,1
145,MECP2 and Associated Rett Syndrome WP3584,0.48273389974400127,1.2486537553141237,0.9093816805433934,"['TET3', 'TAF1']",0.8673999965411625,0,0,2
146,T-cell receptor (TCR) signaling pathway WP69,0.49144475415001954,1.2273972602739727,0.8719500690919895,"['SHC1', 'NFATC2']",0.8673999965411625,0,0,2
147,Vitamin B12 metabolism WP1533,0.49458475670615887,1.5085382513661203,1.0620663584006496,['MCEE'],0.8673999965411625,0,0,1
148,Resistin as a regulator of inflammation WP4481,0.49458475670615887,1.5085382513661203,1.0620663584006496,['PLCD4'],0.8673999965411625,0,0,1
149,Vitamin A and carotenoid metabolism WP716,0.5082064770360913,1.4480874316939891,0.9801632662724336,['SULT1A1'],0.8673999965411625,0,0,1
150,GABA receptor Signaling WP4159,0.5082064770360913,1.4480874316939891,0.9801632662724336,['GPHN'],0.8673999965411625,0,0,1
151,One-carbon metabolism WP241,0.5082064770360913,1.4480874316939891,0.9801632662724336,['MTFMT'],0.8673999965411625,0,0,1
152,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.5082064770360913,1.4480874316939891,0.9801632662724336,['CYP11A1'],0.8673999965411625,0,0,1
153,"GPCRs, Class A Rhodopsin-like WP455",0.5170151850415466,1.167741935483871,0.7703395422883763,"['OXTR', 'GPR37']",0.8673999965411625,0,0,2
154,Neural Crest Differentiation WP2064,0.5170151850415466,1.167741935483871,0.7703395422883763,"['PRTG', 'DCT']",0.8673999965411625,0,0,2
155,IL17 signaling pathway WP2112,0.5214620433403533,1.3922866750735603,0.9065440163398538,['TRAF3'],0.8673999965411625,0,0,1
156,Intraflagellar transport proteins binding to dynein WP4532,0.5214620433403533,1.3922866750735603,0.9065440163398538,['WDR35'],0.8673999965411625,0,0,1
157,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.5214620433403533,1.3922866750735603,0.9065440163398538,['PDK1'],0.8673999965411625,0,0,1
158,DNA IR-damage and cellular response via ATR WP4016,0.533582183479046,1.1310787671232876,0.7104782759952444,"['PRKDC', 'TDP1']",0.8673999965411625,0,0,2
159,BDNF-TrkB Signaling WP3676,0.5343612716963454,1.3406193078324227,0.8401435039895176,['SHC1'],0.8673999965411625,0,0,1
160,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.5343612716963454,1.3406193078324227,0.8401435039895176,['TRAF3'],0.8673999965411625,0,0,1
161,Circadian rhythm related genes WP3594,0.5393136808430528,1.0413619517609054,0.6429971734359886,"['SETX', 'KDM5A', 'PRKDC', 'DYRK1A']",0.8673999965411625,0,0,4
162,Apoptosis Modulation and Signaling WP1772,0.5417189122403221,1.1135932560590094,0.6826416016268697,"['AIFM2', 'TRAF3']",0.8673999965411625,0,0,2
163,Leptin signaling pathway WP2034,0.5417189122403221,1.1135932560590094,0.6826416016268697,"['SHC1', 'LEPR']",0.8673999965411625,0,0,2
164,Alpha 6 Beta 4 signaling pathway WP244,0.5469137157468209,1.2926424668227947,0.7800634907353707,['SHC1'],0.8673999965411625,0,0,1
165,PDGFR-beta pathway WP3972,0.5469137157468209,1.2926424668227947,0.7800634907353707,['SHC1'],0.8673999965411625,0,0,1
166,Alzheimer's disease WP2059,0.5497568322861073,1.096637608966376,0.6560954951102984,"['EIF2AK3', 'CACNA1D']",0.8673999965411625,0,0,2
167,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5576953584142825,1.0801881005929257,0.6307676517329341,"['THRB', 'TTF2']",0.8673999965411625,0,0,2
168,"GPCRs, Other WP117",0.5591286736304535,1.2479743734690032,0.7255419087278556,['GPR143'],0.8673999965411625,0,0,1
169,TGF-beta Signaling Pathway WP366,0.5652382699957309,1.023921832884097,0.5841555150461718,"['SHC1', 'PDK1', 'PIAS1']",0.8673999965411625,0,0,3
170,The influence of laminopathies on Wnt signaling WP4844,0.5710151949702088,1.2062841530054644,0.6759286091211215,['HMGA2'],0.8673999965411625,0,0,1
171,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5710151949702088,1.2062841530054644,0.6759286091211215,['NFATC2'],0.8673999965411625,0,0,1
172,Oxidative Damage WP3941,0.5710151949702088,1.2062841530054644,0.6759286091211215,['TRAF3'],0.8673999965411625,0,0,1
173,B Cell Receptor Signaling Pathway WP23,0.5732723966933423,1.048719475878499,0.5835015264377339,"['SHC1', 'NFATC2']",0.8673999965411625,0,0,2
174,Joubert Syndrome WP4656,0.5732723966933423,1.048719475878499,0.5835015264377339,"['NEK8', 'ARMC9']",0.8673999965411625,0,0,2
175,CAMKK2  Pathway WP4874,0.582582087229139,1.1672836241847346,0.6306660443917301,['NFATC2'],0.8673999965411625,0,0,1
176,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.582582087229139,1.1672836241847346,0.6306660443917301,['PDK1'],0.8673999965411625,0,0,1
177,IL-5 signaling pathway WP127,0.582582087229139,1.1672836241847346,0.6306660443917301,['SHC1'],0.8673999965411625,0,0,1
178,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.582582087229139,1.1672836241847346,0.6306660443917301,['SHC1'],0.8673999965411625,0,0,1
179,NO/cGMP/PKG mediated Neuroprotection WP4008,0.582582087229139,1.1672836241847346,0.6306660443917301,['ACTN2'],0.8673999965411625,0,0,1
180,p38 MAPK Signaling Pathway WP400,0.582582087229139,1.1672836241847346,0.6306660443917301,['SHC1'],0.8673999965411625,0,0,1
181,Aryl Hydrocarbon Receptor Netpath WP2586,0.5938379224508198,1.1307206284153006,0.5892737604604,['PLAGL1'],0.8714193526234411,0,0,1
182,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5957749580349356,0.9774279774279774,0.5062023943929035,"['THRB', 'SHC1', 'TRIP10']",0.8714193526234411,0,0,3
183,Spinal Cord Injury WP2431,0.603218786960873,0.9909551510602365,0.5009033693936501,"['NR4A1', 'PLA2G5']",0.8714193526234411,0,0,2
184,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6047910432386568,1.0963735717834078,0.5513358598886307,['TRAF3'],0.8714193526234411,0,0,1
185,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6047910432386568,1.0963735717834078,0.5513358598886307,['BST2'],0.8714193526234411,0,0,1
186,IL-2 signaling pathway WP49,0.6047910432386568,1.0963735717834078,0.5513358598886307,['SHC1'],0.8714193526234411,0,0,1
187,Myometrial relaxation and contraction pathways WP289,0.6134152655166468,0.9514893001735107,0.46500532440856823,"['RGS5', 'PKIB', 'OXTR']",0.879119204055943,0,0,3
188,Hedgehog Signaling Pathway WP4249,0.6258214026828585,1.033567525370804,0.4844230196008874,['CSNK1G1'],0.882737557468453,0,0,1
189,IL-6 signaling pathway WP364,0.6258214026828585,1.033567525370804,0.4844230196008874,['SHC1'],0.882737557468453,0,0,1
190,PDGF Pathway WP2526,0.6258214026828585,1.033567525370804,0.4844230196008874,['SHC1'],0.882737557468453,0,0,1
191,Androgen receptor signaling pathway WP138,0.6315524175566083,0.9391923145347802,0.431628684137093,"['ZMIZ1', 'PIAS1']",0.8852368041782964,0,0,2
192,22q11.2 copy number variation syndrome WP4657,0.6451177843075692,0.9152765736084619,0.4011861946871775,"['GLUD1', 'XPO1']",0.8852368041782964,0,0,2
193,IL-3 signaling pathway WP286,0.6457355500584375,0.9775513218136169,0.4275469530779382,['SHC1'],0.8852368041782964,0,0,1
194,Splicing factor NOVA regulated synaptic proteins WP4148,0.6552926339720766,0.9517543859649122,0.40228123724538367,['GPHN'],0.8852368041782964,0,0,1
195,Complement system WP2806,0.6552926339720766,0.9517543859649122,0.40228123724538367,['CD59'],0.8852368041782964,0,0,1
196,Glycogen Synthesis and Degradation WP500,0.6552926339720766,0.9517543859649122,0.40228123724538367,['PPP2R2C'],0.8852368041782964,0,0,1
197,Metabolic reprogramming in colon cancer WP4290,0.6552926339720766,0.9517543859649122,0.40228123724538367,['GLUD1'],0.8852368041782964,0,0,1
198,Regulation of Microtubule Cytoskeleton WP2038,0.6552926339720766,0.9517543859649122,0.40228123724538367,['TESK2'],0.8852368041782964,0,0,1
199,mRNA Processing WP411,0.6578815809520255,0.8885561160151324,0.3720653974694636,"['SF3B3', 'SNRPF', 'CLK3']",0.8852368041782964,0,0,3
200,Endochondral Ossification with Skeletal Dysplasias WP4808,0.664592576293761,0.9272803699033207,0.37886922734089773,['SERPINH1'],0.8852368041782964,0,0,1
201,Endochondral Ossification WP474,0.664592576293761,0.9272803699033207,0.37886922734089773,['SERPINH1'],0.8852368041782964,0,0,1
202,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.6736422771705298,0.9040300546448088,0.3571425469922632,['CYP27A1'],0.8852368041782964,0,0,1
203,Histone Modifications WP2369,0.6736422771705298,0.9040300546448088,0.3571425469922632,['SMYD5'],0.8852368041782964,0,0,1
204,Wnt signaling WP428,0.6773018631374635,0.8604696673189823,0.3352718712028362,"['KREMEN1', 'NFATC2']",0.8852368041782964,0,0,2
205,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.6824484522358731,0.8819139011062241,0.3369513296275188,['PDK1'],0.8852368041782964,0,0,1
206,Phosphodiesterases in neuronal function WP4222,0.6824484522358731,0.8819139011062241,0.3369513296275188,['PDE7A'],0.8852368041782964,0,0,1
207,Nonalcoholic fatty liver disease WP4396,0.6837463375556245,0.8532491130916328,0.32437824915954594,"['LEPR', 'EIF2AK3', 'UQCRC2']",0.8852368041782964,0,0,3
208,7q11.23 copy number variation syndrome WP4932,0.6954486477922294,0.8306093528578177,0.3016757431979658,"['CLIP2', 'EIF2AK3']",0.8960588346553725,0,0,2
209,Synaptic Vesicle Pathway WP2267,0.6993561930557948,0.8407675689414157,0.3006543556201902,['CACNA1A'],0.8967821040141292,0,0,1
210,Genotoxicity pathway WP4286,0.7074703102764311,0.8215971187282662,0.28432158227907345,['SEL1L'],0.8995848221548891,0,0,1
211,Cell cycle WP179,0.7127450771831838,0.8027397260273973,0.27183292382428004,"['PRKDC', 'ORC3']",0.8995848221548891,0,0,2
212,G1 to S cell cycle control WP45,0.7153660138165311,0.8032786885245902,0.2690670005210561,['ORC3'],0.8995848221548891,0,0,1
213,IL-4 signaling pathway WP395,0.7153660138165311,0.8032786885245902,0.2690670005210561,['SHC1'],0.8995848221548891,0,0,1
214,Gastrin signaling pathway WP4659,0.7183251938102473,0.7938581965979227,0.26263440643136776,"['SHC1', 'KLF4']",0.8995848221548891,0,0,2
215,Interferon type I signaling pathways WP585,0.7230491671441456,0.7857567118080304,0.25480365804079147,['PIAS1'],0.9012891943936326,0,0,1
216,Cardiac Hypertrophic Response WP2795,0.7305254768083973,0.7689803511219626,0.2414530421163644,['NFATC2'],0.9022157962426289,0,0,1
217,RANKL/RANK signaling pathway WP2018,0.7305254768083973,0.7689803511219626,0.2414530421163644,['TRAF3'],0.9022157962426289,0,0,1
218,Selenium Micronutrient Network WP15,0.7378004966811134,0.7529030054644809,0.22894411665771616,['SELENOI'],0.9070207940850384,0,0,1
219,DNA damage response WP707,0.744879631774149,0.7374818779971005,0.21721248576517946,['PRKDC'],0.9073988241612361,0,0,1
220,Kit receptor signaling pathway WP304,0.744879631774149,0.7374818779971005,0.21721248576517946,['SHC1'],0.9073988241612361,0,0,1
221,p53 transcriptional gene network WP4963,0.7517681423610825,0.7226775956284153,0.2061996644041812,['ISG15'],0.9116464350804077,0,0,1
222,miRNA regulation of DNA damage response WP1530,0.7584711478847777,0.7084538733526198,0.19585244119005146,['PRKDC'],0.9156318361852271,0,0,1
223,AGE/RAGE pathway WP2324,0.7649936306370638,0.694777217318201,0.18612232019656583,['SHC1'],0.9193645426490273,0,0,1
224,MAPK Signaling Pathway WP382,0.7737239696130651,0.7548497829316487,0.19364923684043678,"['NR4A1', 'DUSP1', 'CACNA1A', 'CACNA1D']",0.9248312452732788,0,0,4
225,3q29 copy number variation syndrome WP4906,0.777516293134917,0.668943533697632,0.1683400947003145,['FGFR1OP'],0.9248312452732788,0,0,1
226,Oncostatin M Signaling Pathway WP2374,0.7835257843979238,0.6567312468951814,0.16021044699771841,['SHC1'],0.9248312452732788,0,0,1
227,AMP-activated protein kinase (AMPK) signaling WP1403,0.7893733826823179,0.6449551131928181,0.15254209696533097,['LEPR'],0.9248312452732788,0,0,1
228,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7950634376380213,0.633592177164222,0.14530383029729932,['GPR37'],0.9248312452732788,0,0,1
229,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.799966143802792,0.6680365296803653,0.1490963157093557,"['THRB', 'MAOA']",0.9248312452732788,0,0,2
230,Apoptosis WP254,0.8006001824753757,0.6226210665159224,0.13846694322036718,['TRAF3'],0.9248312452732788,0,0,1
231,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8006001824753757,0.6226210665159224,0.13846694322036718,['TTF2'],0.9248312452732788,0,0,1
232,Toll-like Receptor Signaling Pathway WP75,0.8006001824753757,0.6226210665159224,0.13846694322036718,['TRAF3'],0.9248312452732788,0,0,1
233,Head and Neck Squamous Cell Carcinoma WP4674,0.8163312043422098,0.5918659858460987,0.1201103940885441,['TRAF3'],0.9389560633635717,0,0,1
234,Prolactin Signaling Pathway WP2037,0.8212948165158833,0.5822756918737881,0.11463444355579962,['SHC1'],0.9394974955655264,0,0,1
235,Regulation of Actin Cytoskeleton WP51,0.8305896513505068,0.6215871516296646,0.11537863855195776,"['MYL3', 'MYLK']",0.9394974955655264,0,0,2
236,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8308242777948872,0.563994193989071,0.10452897231440458,['SEC31A'],0.9394974955655264,0,0,1
237,Non-small cell lung cancer WP4255,0.8308242777948872,0.563994193989071,0.10452897231440458,['PDK1'],0.9394974955655264,0,0,1
238,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8353972233503679,0.555275325767129,0.09986512939199124,['KREMEN1'],0.9406993943609185,0,0,1
239,Hepatitis B infection WP4666,0.8409418230550492,0.6057787498561068,0.10494074739305406,"['TRAF3', 'NFATC2']",0.9429807890324401,0,0,2
240,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8524888722781893,0.5229270610596342,0.08345660860671136,['MYLK'],0.9505691773632347,0,0,1
241,Integrated breast cancer pathway WP1984,0.8629041100687683,0.5718199608610568,0.08431582897743449,"['ZMIZ1', 'PIAS1']",0.9505691773632347,0,0,2
242,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8641354308663913,0.5010245901639344,0.07316250345844989,['SHC1'],0.9505691773632347,0,0,1
243,Pathways in clear cell renal cell carcinoma WP4018,0.8678101049715677,0.4941238116625496,0.07005804080706321,['PLOD2'],0.9505691773632347,0,0,1
244,Pyrimidine metabolism WP4022,0.8678101049715677,0.4941238116625496,0.07005804080706321,['POLD3'],0.9505691773632347,0,0,1
245,Small cell lung cancer WP4658,0.8782499697841076,0.4745110727638769,0.06160293606403233,['TRAF3'],0.9505691773632347,0,0,1
246,Wnt signaling pathway and pluripotency WP399,0.8782499697841076,0.4745110727638769,0.06160293606403233,['PPP2R2C'],0.9505691773632347,0,0,1
247,G Protein Signaling Pathways WP35,0.8847488671552809,0.46227406473308114,0.05660612497962644,['PDE7A'],0.9505691773632347,0,0,1
248,Hippo-Merlin Signaling Dysregulation WP4541,0.8878673877904059,0.4563879089714325,0.054279530791612456,['ITGA7'],0.9505691773632347,0,0,1
249,Osteoblast differentiation WP4787,0.8909017480727894,0.45064890710382516,0.05205947058304008,['PRKDC'],0.9505691773632347,0,0,1
250,ErbB signaling pathway WP673,0.8967269876163236,0.43959083033453283,0.047917081889733364,['SHC1'],0.9505691773632347,0,0,1
251,Regulation of toll-like receptor signaling pathway WP1449,0.8967269876163236,0.43959083033453283,0.047917081889733364,['TRAF3'],0.9505691773632347,0,0,1
252,Ras signaling WP4223,0.8987195191213084,0.5140900195694716,0.05489673530355163,"['SHC1', 'PLA2G5']",0.9505691773632347,0,0,2
253,Male infertility WP4673,0.8995222165400097,0.43426163671077755,0.045984627885523655,['PIWIL2'],0.9505691773632347,0,0,1
254,Insulin Signaling WP481,0.9009125785457524,0.510405129699796,0.05325927123380431,"['SHC1', 'SGK2']",0.9505691773632347,0,0,2
255,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9048883323088021,0.42397942783670844,0.04237408656758942,['UQCRC2'],0.9510198943480743,0,0,1
256,NRF2 pathway WP2884,0.9193315244237072,0.39584459256590404,0.03329388578203936,['SLC39A12'],0.9590669225238693,0,0,1
257,Adipogenesis WP236,0.9215163663138992,0.39151223568543597,0.03200015138398519,['ASIP'],0.9590669225238693,0,0,1
258,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9247483309175499,0.5203057811753464,0.04070542202810479,"['PPP2R2C', 'COL5A2', 'ITGA7']",0.9590669225238693,0,0,3
259,Ebola Virus Pathway on Host WP4217,0.9296812264504056,0.3750853825136612,0.027348795108489667,['BST2'],0.9590669225238693,0,0,1
260,PI3K-Akt signaling pathway WP4172,0.9304380591649479,0.5102859226081975,0.03679149886628108,"['PPP2R2C', 'ITGA7', 'SGK2']",0.9590669225238693,0,0,3
261,Chemokine signaling pathway WP3929,0.9419838807243607,0.3494084566820521,0.020883135870130187,['SHC1'],0.9672478162227152,0,0,1
262,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9480240897976387,0.33624431847198816,0.017947163520497484,['SHC1'],0.9697345651365159,0,0,1
263,Breast cancer pathway WP4262,0.955928696922391,0.31824556313167945,0.014343949229905908,['SHC1'],0.9739558217877244,0,0,1
264,Ectoderm Differentiation WP2858,0.9594191677311913,0.30994441303938197,0.012840132671731732,['PDE7A'],0.9739558217877244,0,0,1
265,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9716243782247516,0.27843436268903293,0.008015009160173635,['SHC1'],0.9807785382373627,0,0,1
266,Nuclear Receptors Meta-Pathway WP2882,0.9734592954146958,0.3600468093894128,0.009684995497256375,"['SULT1A1', 'SLC39A12']",0.9807785382373627,0,0,2
267,EGF/EGFR signaling pathway WP437,0.9801654035500439,0.2526937581774802,0.005062452202842574,['SHC1'],0.9838364350240141,0,0,1
268,IL-18 signaling pathway WP4754,0.9936026010734094,0.19546716832392727,0.0012544985088092143,['NR4A1'],0.9936026010734094,0,0,1
